Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social Drivers of Health and Cognition in Cirrhosis: A Scoping Review.

Clinical nursing research·2025
Same author

An Innovative Forum for Gastroenterology and Hepatology Issues.

Gastro hep advances·2024
Same author

Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases.

Gastro hep advances·2024
Same author

Evaluation of the Patient with Markedly Abnormal Liver Enzymes.

Clinics in liver disease·2022
Same author

Posttransplant complications in the setting of acute-on-chronic liver failure and considerations regarding immunosuppression.

Clinical liver disease·2022
Same author

Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.

Digestive diseases and sciences·2022
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Primary sclerosing cholangitis.

Fredric D Gordon1

  • 1Lahey Clinic Medical Center, Hepatobiliary and Liver Transplantation, 41 Mall Road, 4 West, Burlington, MA 01805, USA. fredric_d_gordon@lahey.org

The Surgical Clinics of North America
|November 11, 2008
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a progressive liver disease with no current medical treatments. This review covers PSC epidemiology, diagnosis, and management, highlighting future research needs.

Related Experiment Videos

Last Updated: Jun 28, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Area of Science:

  • Hepatology
  • Gastroenterology
  • Chronic liver disease research

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic, progressive hepatobiliary disorder.
  • The disease course is variable, sometimes leading to fatal outcomes.
  • Currently, no effective medical therapies exist for PSC.

Purpose of the Study:

  • To describe the epidemiology of primary sclerosing cholangitis.
  • To outline current diagnostic approaches for PSC.
  • To discuss existing and potential treatment options for PSC.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of diagnostic criteria and methods.
  • Review of current and emerging treatment strategies.

Main Results:

  • PSC affects specific populations, with varying prevalence and incidence rates.
  • Diagnosis relies on clinical, biochemical, and imaging findings.
  • Management focuses on symptom control and complication prevention, as effective therapies are lacking.

Conclusions:

  • PSC remains a significant clinical challenge due to its progressive nature and lack of targeted therapies.
  • Further research into PSC pathogenesis is crucial for developing effective treatments.
  • Improved understanding of PSC epidemiology and outcomes is needed.